[Form 4] Insmed, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Insider Trade Summary
Net Seller: 6,830 shares ($750,008)
Net Sell
7 txns
Insider
Lewis William
Role
Chair and CEO
Sold
6,830 shs ($750K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 6,830 | $0.00 | -- |
| Exercise | Common Stock | 6,830 | $10.85 | $74K |
| Sale | Common Stock | 1,693 | $108.80 | $184K |
| Sale | Common Stock | 3,199 | $109.68 | $351K |
| Sale | Common Stock | 1,938 | $110.91 | $215K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 6,865 shares (Indirect, By the Katie Procter Dynasty Trust);
Common Stock — 240,754 shares (Indirect, By the Katie Procter Dynasty Trust);
Common Stock — 303,911 shares (Direct)
Footnotes (1)
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. This is the weighted average sales price representing 1,693 shares sold at prices ranging from $108.24 to $109.23 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. This is the weighted average sales price representing 3,199 shares sold at prices ranging from $109.25 to $110.23 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. This is the weighted average sales price representing 1,938 shares sold at prices ranging from $110.26 to $111.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
